** charts before earnings **
** charts after earnings **
** 2 weeks later **
- Reports Q4 (Dec) loss of $0.16 per share, may not be comparable to the S&P Capital IQ Consensus of ($0.04); revenues rose 113.9% year/year to $111 mln vs the $98.72 mln S&P Capital IQ Consensus.
- Adjusted EBITDA of $6.5 million compared to $3.6 million, an increase of 82%.
- Co issues in-line guidance for FY19, sees FY19 revs of At least $600 mln vs. $602.19 mln S&P Capital IQ Consensus.
- Adjusted EBITDA of at least $51 million, an increase greater than 23% from growth of 86% in 2018;
- The opening of at least 80 veterinarian wellness clinics
- 2023 Outlook
- Net sales of approximately $1.0 billion;
- Adjusted EBITDA margin of greater than 15%;
- Wellness center locations of 1,000.
No comments:
Post a Comment